Document is current
Any future updates will be listed below
-
Authors
Silas, Sukrit https://orcid.org/0000-0003-3251-8579
Carion, Héloïse
Makarova, Kira S. https://orcid.org/0000-0002-8174-2844
Sanchez Godinez, David
Haniyur, Surabhi https://orcid.org/0009-0003-6914-327X
Volino, Lucy
Yee, Wearn-Xin
Fossati, Andrea
Swaney, Danielle https://orcid.org/0000-0001-6119-6084
Bocek, Michael
Koonin, Eugene V. https://orcid.org/0000-0003-3943-8299
Bondy-Denomy, Joseph https://orcid.org/0000-0002-4909-9481
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01 AI167412)
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Vallee Foundation
Kinship Foundation
- License Information
-
More Information
Article History
Received: 22 June 2025
Accepted: 1 August 2025
First Online: 22 August 2025
Competing interests
: S.S. is co-founder and equity holder in BillionToOne Inc., BK Labs Inc., and CK Labs Inc., and a scientific advisory board member of Junevity Inc. J.B.D. is a scientific advisory board member of SNIPR Biome, Excision Biotherapeutics, and LeapFrog Bio, consults for BiomX, and is a scientific advisory board member and co-founder of Acrigen Biosciences and ePhective Therapeutics. The Bondy-Denomy lab received research support from Felix Biotechnology.
